The Journal of Heart and Lung Transplantation
Volume 29, Issue 11 , Pages 1314-1315 , November 2010

Effect of preservation solution choice on antibody-mediated rejection after heart transplantation

  • Divya Ratan Verma, MD

      Affiliations

    • Division of Cardiology, University of Utah School of Medicine and Veterans Affairs Medical Center, Salt Lake City, Utah
    • Heart Failure Prevention and Treatment Program, Intermountain Medical Center, Salt Lake City, Utah
    • Utah Transplantation Affiliated Hospitals (U.T.A.H.), Cardiac Transplant Program, Salt Lake City, Utah
    • ,
  • Stavros G. Drakos, MD

      Affiliations

    • Division of Cardiology, University of Utah School of Medicine and Veterans Affairs Medical Center, Salt Lake City, Utah
    • Heart Failure Prevention and Treatment Program, Intermountain Medical Center, Salt Lake City, Utah
    • Utah Transplantation Affiliated Hospitals (U.T.A.H.), Cardiac Transplant Program, Salt Lake City, Utah
    • ,
  • Josef Stehlik, MD, MPH

      Affiliations

    • Division of Cardiology, University of Utah School of Medicine and Veterans Affairs Medical Center, Salt Lake City, Utah
    • Utah Transplantation Affiliated Hospitals (U.T.A.H.), Cardiac Transplant Program, Salt Lake City, Utah
    • ,
  • Benjamin D. Horne, PhD

      Affiliations

    • Heart Failure Prevention and Treatment Program, Intermountain Medical Center, Salt Lake City, Utah
    • Utah Transplantation Affiliated Hospitals (U.T.A.H.), Cardiac Transplant Program, Salt Lake City, Utah
    • ,
  • Abdallah G. Kfoury, MD

      Affiliations

    • Division of Cardiology, University of Utah School of Medicine and Veterans Affairs Medical Center, Salt Lake City, Utah
    • Heart Failure Prevention and Treatment Program, Intermountain Medical Center, Salt Lake City, Utah
    • Utah Transplantation Affiliated Hospitals (U.T.A.H.), Cardiac Transplant Program, Salt Lake City, Utah

References 

  1. Diepenhorst GM, van Gulik TM, Hack CE. Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg. 2009;249:889–899
  2. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710–1720
  3. Kfoury AG, Hammond ME. Controversies in defining cardiac antibody-mediated rejection: need for updated criteria. J Heart Lung Transplant. 2010;29:389–394
  4. Kfoury AG, Hammond ME, Snow GL, et al. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant. 2009;28:781–784
  5. Yang Q, He GW. Effect of cardioplegic and organ preservation solutions and their components on coronary endothelium-derived relaxing factors. Ann Thorac Surg. 2005;80:757–767

PII: S1053-2498(10)00400-6

doi: 10.1016/j.healun.2010.06.012

The Journal of Heart and Lung Transplantation
Volume 29, Issue 11 , Pages 1314-1315 , November 2010

Article Tools

* Image Usage & Resolution